This topic contains a solution. Click here to go to the answer

Author Question: ________ is the ongoing communication among different people and functions that is necessary for an ... (Read 91 times)

james0929

  • Hero Member
  • *****
  • Posts: 586
________ is the ongoing communication among different people and functions that is necessary for an organization to achieve its goals.
 
  A) Instant messaging
  B) Mutual adjustment
  C) Divisional alignment
  D) Functional integration

Question 2

You are the manager who strongly believes in participative decision making. You will probably be more comfortable with TQM than with reengineering.
 
  Indicate whether the statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

stillxalice

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

B

Answer to Question 2

TRUE




james0929

  • Member
  • Posts: 586
Reply 2 on: Jul 7, 2018
Excellent


raili21

  • Member
  • Posts: 324
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library